Free Research Reports on ONCY, CLSN, ETRM and MOH Issued by the Bedford Report

NEW YORK, NY -- (Marketwire) -- 02/11/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Oncolytics Biotech, Inc. (NASDAQ: ONCY)(TSX: ONC) shares soared over 20 percent on nearly 9 million shares traded Friday. The company has reported that its cancer drug Reolysin was effective in shrinking tumors in a recent Phase 2 clinical trial.

Find out more about Oncolytics Biotech including full access to the free equity report at: www.BedfordReport.com/ONCY

Celsion Corporation (NASDAQ: CLSN) shares rallied over 11 percent on 7.25 million shares traded Friday. Shares of the company have fallen sharply since reporting ThermoDox did not meet the primary endpoint of the Phase III HEAT Study.

Find out more about Celsion including full access to the free equity report at: www.BedfordReport.com/CLSN

EnteroMedics Inc. (NASDAQ: ETRM) shares plunged 55 percent on over 15 million shares traded Friday, which was nearly thirty times its average daily volume. The company reported VBLOC, a device for the treatment of obesity, did not meet its predefined primary efficacy endpoints in a recent clinical trial.

Find out more about EnteroMedics including full access to the free equity report at: www.BedfordReport.com/ETRM

Molina Healthcare, Inc. (NYSE: MOH) shares surged 10 percent on nearly 2 million shares traded Friday. The company swung to a net income of $25.6 million in the fourth quarter of 2012, compared to a net loss of $33.0 million a year ago.

Find out more about Molina Healthcare including full access to the free equity report at: www.BedfordReport.com/MOH

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.